Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01636635 · ClinicalTrials.gov registry record · NA

Effect of Age and Weight Loss on Inflammation and Iron Homeostasis

A NA study, sponsored by Tufts University.

Completed
Registry status
NA
Development phase
44
Enrollment target

NCT01636635: Completed NA study, sponsored by Tufts University.

NCT01636635 is a NA study that has completed, run by Tufts University. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01636635, a NA study, has completed, sponsored by Tufts University.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effect of aging and weight loss on iron status and immune response in obese women. Iron deficiency and immune impairment are two of the numerous complications of obesity. The central hypothesis is that obesity-induced inflammation causes lower iron status through decreased iron absorption and availability in young and older obese women. Furthermore, the investigators hypothesize that this can be corrected with weight loss in both young and older obese women.

Primary Outcome

The investigators will determine the change in hepcidin at baseline and after 12-16 weeks of calorie restriction.

Interventions

  • OTHER Calorie Restriction

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2011-03
Est. Completion 2013-11
Phase NA
Tufts University

163 total trials

What the finished NCT01636635 record still lists

NCT01636635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Calorie Restriction is the first listed.

NCT01636635 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01636635 about?

NCT01636635 is a clinical study titled "Effect of Age and Weight Loss on Inflammation and Iron Homeostasis". The purpose of this study is to evaluate the effect of aging and weight loss on iron status and immune response in obese women. Iron deficiency and immune impairment are two of the numerous complications of obesity. The central hypothesis is that obesity-induced inflammation causes lower iron status...

What is the current status of trial NCT01636635?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2011-03. Estimated completion is 2013-11.

What interventions are being tested in trial NCT01636635?

The interventions under investigation include: Calorie Restriction (OTHER).

Who is sponsoring clinical trial NCT01636635?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01636635's enrollment target sits among peer trials

44 1423rd of 2000 higher than 566 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01636635, the US trial registry maintained by the National Library of Medicine. NCT01636635 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.